Cargando…

In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine

The antidepressant vortioxetine has high affinity for the ionotropic 5‐HT(3) receptor (5‐HT(3)R) as well as other targets including the 5‐HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweimer, Judith V., Brouard, Julia T., Li, Yan, Sánchez, Connie, Sharp, Trevor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314076/
https://www.ncbi.nlm.nih.gov/pubmed/35146812
http://dx.doi.org/10.1111/ejn.15623
_version_ 1784754231771660288
author Schweimer, Judith V.
Brouard, Julia T.
Li, Yan
Sánchez, Connie
Sharp, Trevor
author_facet Schweimer, Judith V.
Brouard, Julia T.
Li, Yan
Sánchez, Connie
Sharp, Trevor
author_sort Schweimer, Judith V.
collection PubMed
description The antidepressant vortioxetine has high affinity for the ionotropic 5‐HT(3) receptor (5‐HT(3)R) as well as other targets including the 5‐HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhibits cortical 5‐HT(3)R‐expressing interneurons (5‐HT(3)R‐INs) to disinhibit excitatory pyramidal neurons. The current study determined for the first time the effect of vortioxetine on the in vivo firing of putative 5‐HT(3)R‐INs whilst simultaneously recording pyramidal neuron activity using cortical slow‐wave oscillations as a readout. Extracellular single unit and local field potential recordings were made in superficial layers of the prefrontal cortex of urethane‐anaesthetised rats. 5‐HT(3)R‐INs were identified by a short‐latency excitation evoked by electrical stimulation of the dorsal raphe nucleus (DRN). Juxtacellular‐labelling found such neurons had the morphological and immunohistochemical properties of 5‐HT(3)R‐INs: basket cell or bipolar cell morphology, expression of 5‐HT(3)R‐IN markers and parvalbumin‐immunonegative. Vortioxetine inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs and simultaneously decreased cortical slow wave oscillations, indicative of pyramidal neuron activation. Likewise, the 5‐HT(3)R antagonist ondansetron inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs. However unlike vortioxetine, ondansetron did not decrease cortical slow‐wave oscillations, suggesting a dissociation between this effect and inhibition of 5‐HT(3)R‐INs. The 5‐HT reuptake inhibitor escitalopram had no consistent effect on any electrophysiological parameter measured. Overall, the current findings suggest that vortioxetine simultaneously inhibits (DRN‐evoked) 5‐HT(3)R‐INs and excites pyramidal neurons, thereby changing the excitatory:inhibitory balance in cortex. However, under the current experimental conditions, these two effects were dissociable with only the former likely involving a 5‐HT(3)R‐mediated mechanism.
format Online
Article
Text
id pubmed-9314076
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93140762022-07-30 In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine Schweimer, Judith V. Brouard, Julia T. Li, Yan Sánchez, Connie Sharp, Trevor Eur J Neurosci Molecular and Synaptic Mechanisms The antidepressant vortioxetine has high affinity for the ionotropic 5‐HT(3) receptor (5‐HT(3)R) as well as other targets including the 5‐HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhibits cortical 5‐HT(3)R‐expressing interneurons (5‐HT(3)R‐INs) to disinhibit excitatory pyramidal neurons. The current study determined for the first time the effect of vortioxetine on the in vivo firing of putative 5‐HT(3)R‐INs whilst simultaneously recording pyramidal neuron activity using cortical slow‐wave oscillations as a readout. Extracellular single unit and local field potential recordings were made in superficial layers of the prefrontal cortex of urethane‐anaesthetised rats. 5‐HT(3)R‐INs were identified by a short‐latency excitation evoked by electrical stimulation of the dorsal raphe nucleus (DRN). Juxtacellular‐labelling found such neurons had the morphological and immunohistochemical properties of 5‐HT(3)R‐INs: basket cell or bipolar cell morphology, expression of 5‐HT(3)R‐IN markers and parvalbumin‐immunonegative. Vortioxetine inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs and simultaneously decreased cortical slow wave oscillations, indicative of pyramidal neuron activation. Likewise, the 5‐HT(3)R antagonist ondansetron inhibited the short‐latency DRN‐evoked excitation of 5‐HT(3)R‐INs. However unlike vortioxetine, ondansetron did not decrease cortical slow‐wave oscillations, suggesting a dissociation between this effect and inhibition of 5‐HT(3)R‐INs. The 5‐HT reuptake inhibitor escitalopram had no consistent effect on any electrophysiological parameter measured. Overall, the current findings suggest that vortioxetine simultaneously inhibits (DRN‐evoked) 5‐HT(3)R‐INs and excites pyramidal neurons, thereby changing the excitatory:inhibitory balance in cortex. However, under the current experimental conditions, these two effects were dissociable with only the former likely involving a 5‐HT(3)R‐mediated mechanism. John Wiley and Sons Inc. 2022-03-03 2022-03 /pmc/articles/PMC9314076/ /pubmed/35146812 http://dx.doi.org/10.1111/ejn.15623 Text en © 2022 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Molecular and Synaptic Mechanisms
Schweimer, Judith V.
Brouard, Julia T.
Li, Yan
Sánchez, Connie
Sharp, Trevor
In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
title In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
title_full In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
title_fullStr In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
title_full_unstemmed In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
title_short In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
title_sort in vivo electrophysiological study of the targeting of 5‐ht(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
topic Molecular and Synaptic Mechanisms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314076/
https://www.ncbi.nlm.nih.gov/pubmed/35146812
http://dx.doi.org/10.1111/ejn.15623
work_keys_str_mv AT schweimerjudithv invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine
AT brouardjuliat invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine
AT liyan invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine
AT sanchezconnie invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine
AT sharptrevor invivoelectrophysiologicalstudyofthetargetingof5ht3receptorexpressingcorticalinterneuronsbythemultimodalantidepressantvortioxetine